Gilman Hill Asset Management, LLC Pfizer Inc Transaction History

Gilman Hill Asset Management, LLC

$552 Million
Q2 2024

A detailed history of Gilman Hill Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 267,846 shares of PFE stock, worth $7.65 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

267,846

Previous 258,938 3.44%

Holding current value

$7.65 Million

Previous $7.19 Million 4.3%

% of portfolio

1.36%

Previous 1.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $225,016 - $263,676	8,908 Added 3.44%	267,846 $7.49 Million
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $429,877 - $493,636	16,604 Added 6.85%	258,938 $7.19 Million
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $269,191 - $349,649	-10,302 Reduced 4.08%	242,334 $6.98 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $159,102 - $185,974	4,958 Added 2.0%	252,636 $8.38 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $233,624 - $270,297	6,468 Added 2.68%	247,678 $9.08 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $594,828 - $774,379	15,101 Added 6.68%	241,210 $9.84 Million
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $357,296 - $466,411	-8,558 Reduced 3.65%	226,109 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $421,627 - $514,701	9,635 Added 4.28%	234,667 $10.3 Million
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $630,574 - $747,663	13,552 Added 6.41%	225,032 $11.8 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $1.04 Million - $1.29 Million	-22,839 Reduced 9.75%	211,480 $10.9 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $520,301 - $771,260	12,592 Added 5.68%	234,319 $13.8 Million
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $39,250 - $50,420	-1,000 Reduced 0.45%	221,727 $9.54 Million
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $2.29 Million - $2.59 Million	63,774 Added 40.12%	222,727 $8.72 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $1.17 Million - $1.32 Million	35,078 Added 28.32%	158,953 $5.76 Million
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $23,161 - $29,451	692 Added 0.56%	123,875 $4.56 Million
Q3 2020 Oct 16, 2020	BUY	$31.75 - $37.25 $286,416 - $336,032	9,021 Added 7.9%	123,183 $4.52 Million
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $11,234 - $13,629	-373 Reduced 0.33%	114,162 $3.73 Million
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $152,124 - $217,353	5,628 Added 5.17%	114,535 $3.74 Million
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $251,936 - $285,916	-7,653 Reduced 6.57%	108,907 $4.27 Million
Q3 2019 Oct 18, 2019	BUY	$32.49 - $42.13 $837,072 - $1.09 Million	25,764 Added 28.38%	116,560 $4.19 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $307,932 - $345,737	-8,327 Reduced 8.4%	90,796 $3.93 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $617,325 - $678,234	-16,462 Reduced 14.24%	99,123 $4.21 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $470,026 - $535,881	-12,218 Reduced 9.56%	115,585 $5.05 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $54,634 - $66,268	-1,585 Reduced 1.22%	127,803 $5.63 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $67,312 - $71,761	-2,041 Reduced 1.55%	129,388 $4.69 Million
Q1 2018 Apr 26, 2018	SELL	$31.91 - $37.02 $75,339 - $87,404	-2,361 Reduced 1.76%	131,429 $4.66 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $63,193 - $67,051	-1,900 Reduced 1.4%	133,790 $4.85 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $4.21 Million - $4.63 Million	135,690	135,690 $4.84 Million

Others Institutions Holding PFE

# of Institutions

3,216

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.

Account

Gilman Hill Asset Management, LLC Pfizer Inc Transaction History